---
schema_version: "secwatch.filing_event.v1"
accession: "0001625297-25-000076"
form_type: "8-K"
ticker: "INDV"
cik: "0001625297"
company_name: "Indivior Pharmaceuticals, Inc."
filed_at: "2025-12-18T23:59:59+00:00"
generated_at: "2026-05-16T12:44:51.276324+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.3
confidence: "high"
source: SEC EDGAR
---

# Indivior CEO and CFO receive base salary increases effective Jan 1, 2026

## Summary
- CEO Joseph Ciaffoni salary increased from $1,050,000 to $1,115,000.
- CFO Ryan Preblick salary increased from $559,000 to $604,000.
- Changes effective January 1, 2026, approved by Board on Dec 12, 2025.
- Based on competitive market review and Compensation Committee recommendation.

## SEC filing metadata
- accession: 0001625297-25-000076
- form_type: 8-K
- ticker: INDV
- cik: 0001625297
- company_name: Indivior Pharmaceuticals, Inc.
- filed_at: 2025-12-18T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.3
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1625297/000162529725000076/0001625297-25-000076-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1625297/000162529725000076/indv-20251212.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001625297-25-000076
- JSON: https://secwatch.observer/filing/0001625297-25-000076.json
- Plain text: https://secwatch.observer/filing/0001625297-25-000076.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.